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Abstract We show here that TPPCTMP conversion can take
place in rat liver mitochondria. This occurs via the novel, putative
TPP pyrophosphatase localised in the mitochondrial matrix, as
shown both by digitonin titration and by an HPLC enzyme assay
carried out on the mitochondrial matrix fraction. Certain
features of the reaction, including the substrate and pH
dependence, are reported. Additional evidence is given that
externally added TMP can cross the mitochondrial membrane in
a manner consistent with the occurrence of a carrier-mediated
process. This can occur both via the TPP translocator and via a
novel translocator, inhibited by CAT but different from the
ADP/ATP carrier.
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1. Introduction
Although the structural and functional biology of mito-
chondrial energy metabolism in mammals has been deeply
investigated in the last 40 years, the mechanisms by which
the vitamin-derived cofactors involved in energy metabolism
are synthesised and degraded in the mitochondrial compart-
ments are still rather obscure. Some cofactor synthesis occurs
in mitochondria from the vitamins and/or precursors taken
up. Indeed, this uptake of certain vitamins and the synthesis
of certain cofactors in isolated mammalian mitochondria has
already been reported, as has the contrasting fact that several
cytosolically synthesised cofactors enter isolated mitochondria
(for references see [1]). By contrast, the knowledge of mito-
chondrial cofactor degradation is rather poor. The existence
of a speci¢c mitochondrial pyridoxal 5P-phosphate phospha-
tase has been suggested [2] and more recently, NAD and
£avin cofactor hydrolysis have been shown to occur, catalysed
by enzymes localised in the outer mitochondrial compart-
ments [3,1].
The above described state of the art requires further inves-
tigation regarding the occurrence of mitochondrial enzymes
involved in vitamin and vitamin cofactor metabolism. In par-
ticular, it would be worthwhile to gain a better insight into the
mitochondrial metabolism of TPP, which represents 30% of
the total cellular cofactor in hepatocytes [4]. As far as TPP
synthesis and localisation are concerned, the possibility of
TPP synthesis in RLM has long since been ruled out [5,6].
Consistently, in hepatocytes, externally added thiamine is con-
verted to TPP via the cytosolic thiamine pyrophosphokinase
(EC 2.7.6.2) [7], with TPP being taken up by RLM in a car-
rier-mediated process [8]. However, no information is avail-
able concerning TPP catabolism and the aim of the current
investigation was to ascertain whether and how mitochondria
can hydrolyse TPP and what the fate of the hydrolysis prod-
uct(s) is. The occurrence of TPPCTMP conversion is shown
in RLM as catalysed by the putative TPPase with additional
evidence that TMP can cross the mitochondrial membrane in
exchange for TPP.
2. Materials and methods
All reagents and enzymes were from Sigma (St. Louis, MO, USA).
Mitochondrial substrates were used as Tris salts at pH 7.0^7.3. Dig-
itonin was from Merck. H2O and CH3CN used for HPLC were from
J.T. Baker (Deventer, The Netherlands).
RLM and pRLM were obtained from male Wistar rats (150^200 g)
[1], and resuspended up to 50^60 mg protein in the standard medium
consisting of 0.25 M sucrose, 20 mM Tris-HCl, pH 7.25, 1 mM
EDTA. Mitochondrial protein was determined according to Waddel
and Hill [9].
The TPP loading procedure was carried out as described [8], by
adding RLM with 450 WM TPP.
The mitochondrial matrix fraction was obtained from pRLM [10],
with the fraction purity checked by measuring the activities of MAO
(EC 1.4.3.4), ADK (EC 2.7.4.3) and GDH (EC 1.4.1.3), as marker
enzymes for the outer membrane, intermembrane space and matrix,
respectively [11^13].
Digitonin titration was carried out according to Boyer et al. [3].
Brie£y, RLM (5 mg) were incubated at 0^2‡C for 15 min in a medium
(0.5 ml) consisting of 0.22 M mannitol, 0.07 M sucrose, 2 mM
HEPES-Tris, pH 7.4, in the presence of varying amounts of digitonin
and then centrifuged at 20 000Ug for 2 min. The lysosomal and mi-
crosomal contamination was checked by measuring the acid phospha-
tase (EC 3.1.3.2) and the NADPH-cytochrome c reductase (EC
1.6.2.4) activities [14,15].
The TPP and TMP mitochondrial metabolism was investigated as
follows: either pRLM (solubilised with Triton X-100) or mitochon-
drial matrix fraction was incubated at 25‡C in 1.4 mL of 50 mM
sodium acetate bu¡er pH 5.0 for 1 min and then either TPP or
TMP was added. At various points in time, aliquots (200 Wl) were
taken from the reaction mixture and rapidly added with SDS (0.5%)
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to stop any enzymatic reaction. TPP and TMP hydrolysis products
were checked by photometric measurements and HPLC analysis. In
the former case, the rate of Pi appearance was measured [16], with
correction made for the mitochondrial endogenous Pi. In the case of
HPLC measurements, neutralised perchloric extracts (5^40 Wl) [1] were
analysed for thiamine, TMP and TPP amount using a Kontron In-
strument HPLC system (including a model 420 pump and model 425
gradient former equipped with a 450 MT2 data system). Use was
made of a RP-8 Lichrosorb-NH2 column (12.5 cmU3 mm) equipped
with a guard column (4 cmU4 mm). The solvent was of 70 mM
potassium phosphate bu¡er (pH 7.4) with 60% CH3CN. Elution
was carried out at room temperature with a £ow rate of 1.5 ml/
min. Eluted thiamine derivatives were converted to thiochrome [17]
and detected £uorimetrically by means of a Kontron Instruments
SFM 25 £uorimeter (excitation and emission wavelengths at 375 nm
and 435 nm, respectively). Thiamine, TMP and TPP retention times
(about 2, 4.5 and 5.5 min, respectively) were measured in each experi-
ment, with a quantitative determination carried out by means of a
calibration curve, obtained using standard solutions, the concentra-
tions of which were determined photometrically (O266nm = 8.5 mM31
cm31 for TMP and TPP). Under the conditions used, TMP and TPP
£uorescence did not di¡er signi¢cantly. Since the rates of Pi appear-
ance and TMP formation showed no signi¢cant di¡erence, either
photometric or HPLC assay was used.
TMP and TPP uptake assays were carried out as follows: RLM
(6^9 mg protein) were incubated for 1 min at 25‡C in 0.35 ml of the
standard medium in the presence of [14C]sucrose and 3H2O (0.1 WCi
each). Uptake reaction was started by adding the substrate and
stopped when appropriate by rapidly centrifuging at 14 000Ug in a
refrigerated Ole Dich microcentrifuge equipped with an Eppendorf
rotor. Mitochondrial pellets were carefully separated from superna-
tants, washed in 1 ml of ice-cold standard medium and centrifuged to
obtain perchloric extracts, and the amount of thiamine derivative
actually taken up by RLM was calculated [8]. The content of TMP
and TPP in neutralised extracts was measured via HPLC, whereas the
content of TMP plus TPP was measured by directly following the
£uorescence of the thiochrome, using a LS50 Perkin Elmer spectro-
photo£uorimeter. When only TMP content was found to increase (as
checked via HPLC), the thiochrome £uorescence was used to measure
TMP uptake. In another experimental approach, the amount of TPP
in the neutralised extracts was estimated enzymatically by measuring
the pyruvate decarboxylase (EC 4.1.1.1) activity, which is restored
when TPP is added to the partially inactive apoenzyme [8].
Pi (via Pi carrier), succinate-malate exchange (via dicarboxylate
carrier), cis-aconitate transport (via tricarboxylate carrier), oxaloace-
tate uptake (via oxodicarboxylate carrier) and ADP/ATP exchange
(via adenine nucleotide carrier) were determined as described else-
where [18].
3. Results
3.1. TPP hydrolysis by RLM
In order to determine whether RLM can accomplish thi-
amine derivative metabolism, either TPP or TMP (1 mM
each) was added to pRLM ruptured with Triton X-100
(0.5%) and Pi appearance in the reaction medium was fol-
lowed. With TPP, the amount of Pi in the reaction mixture
was found to linearly increase with time up to 80 min, at a
rate of Pi appearance of 0.7 þ 0.3 nmol Pi/min/mg protein in
three di¡erent experiments. Pi appearance was prevented by
SDS (0.1%), which denatures the proteins, and by NaF (10
mM), an inhibitor of cell phosphatases and phosphodiester-
ases. By contrast, no Pi formation was found when TMP was
added to ruptured pRLM. Taken together, these results show
that RLM can hydrolyse externally added TPP yielding TMP
as the product.
In order to identify the mitochondrial compartment in
which TPP metabolism takes place, the release of TPP de-
phosphorylating activity from RLM was measured as a func-
tion of the digitonin/protein ratio (Fig. 1). First, as a control,
the release pro¢les of the lysosomal acid phosphatase and the
microsomal NADPH-cytochrome c reductase from the mito-
chondrial pellet were measured. Both enzymes were released
almost completely at 0.1 mg digitonin/mg protein ratios (90%
and 70% respectively). By contrast, the release of MAO, ADK
and GDH, used as mitochondrial marker enzymes, required
digitonin/protein ratios higher than 0.1. The pro¢le of the
TPP dephosphorylating activity followed that of GDH, thus
showing that the enzyme that hydrolyses TPP is localised in
the matrix fraction.
In order to identify the product(s) of TPP hydrolysis cata-
lysed by a mitochondrial matrix protein, in a ¢rst set of ex-
periments TPP (0.2 mM) was added to the mitochondrial
matrix fraction and neutralised perchloric extracts, obtained
at di¡erent incubation times, were analysed by HPLC (Fig. 2).
The matrix contents of TPP and TMP were found to be about
500 and 70 pmol/mg matrix protein, respectively, whereas no
thiamine was detectable. Upon TPP addition, TMP was ac-
cumulated in the mitochondrial matrix, at a rate of 0.23 nmol/
min/mg protein. Interestingly, both TPP and TMP failed to
cause thiamine formation within the observation time. These
results show that TPPCTMP+Pi conversion occurs in the
mitochondrial matrix catalysed by the novel mitochondrial
TPPase (EC 3.6.1.-).
Some features of TPP hydrolysis catalysed by a matrix pro-
tein were then investigated (Fig. 3). The rate of TPPCTMP
conversion was studied as a function of the amount of mito-
chondrial protein in the 0^0.8 mg range and a linear depend-
ence was found, with the apparent rate constant being about
0.92 nmol/min/mg. The rate of TPP hydrolysis showed a
broad maximum of activity in the 5^7 pH range and was
very low at alkaline pH (Fig. 3A). Finally, the dependence
of the rate of TPP hydrolysis was studied as a function of
the substrate concentration: hyperbolic characteristics were
found with Km and Vmax values equal to 0.50 þ 0.07 mM
and 1.07 þ 0.07 nmol/min/mg, respectively (Fig. 3B).
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Fig. 1. Submitochondrial localisation of TPPase activity: digitonin
titration. Digitonin titration was carried out as described in Section
2. The enzymes measured were acid phosphatase (F), NADPH-cyto-
chrome c reductase (8), ADK (E), MAO (a), GDH (O) and
TPPase (b). Values are given as the mean of four experiments car-
ried out with di¡erent mitochondrial preparations. The standard er-
rors, not reported for clarity’s sake, ranged between 2 and 20% of
the mean values.
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3.2. TMP transport in isolated mitochondria
In order to determine whether RLM are permeable to
TMP, a series of experiments was carried out in which TMP
was added to mitochondria and £uorimetric measurements
made of the intramitochondrial TMP content (Fig. 4), thus
measuring the net increase of the thiamine derivative content
in RLM. In Fig. 4A the time course of TMP uptake by RLM
is shown. The TMP taken up was found to increase with time,
with an initial rate equal to about 220 pmol/min/mg protein
and a maximum uptake, reached after about 3 min incuba-
tion, of about 390 pmol/mg protein. The dependence of TMP
uptake rate on temperature was investigated at temperatures
ranging between 1 and 26‡C and reported as an Arrhenius
plot (Fig. 4B). An activation energy value of about 7 kcal/
mol was calculated, in fairly good agreement with the value
obtained for other transport processes (for references see [19]).
The dependence of the uptake rate on extramitochondrial
TMP concentration was also investigated (Fig. 4C). Satura-
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Fig. 4. Some features of TMP uptake by isolated RLM. TMP (200
WM) uptake reaction was studied as described in Section 2. A: The
time course of TMP uptake by isolated RLM. B: The temperature
dependence of the rate of TMP uptake (measured in 45 s) reported
as the Arrhenius plot. C: The dependence of the rate of TMP up-
take on the extramitochondrial concentration of TMP.
Fig. 3. Some features of TPP hydrolysis catalysed by the mitochon-
drial matrix fraction. TPP (1 mM) hydrolysis was assayed by photo-
metrically measuring the rate of Pi appearance (V) as described in
Section 2. A: pH pro¢le of the rate of TPP hydrolysis. The rate of
TPP hydrolysis measured at each pH is reported as a percentage of
that measured at pH 5.0. B: The dependence of the rate of TPP hy-
drolysis on the substrate concentration.
Fig. 2. HPLC evidence of TMP appearance following TPP addition
to the mitochondrial matrix fraction. Mitochondrial matrix fraction
(0.8 mg protein) was incubated for 1 min under the experimental
conditions described in Section 2 and then TPP (0.2 mM) was
added. The ¢gure reports the chromatograms of the mitochondrial
matrix fraction before (dotted line) and after 80 min incubation
with TPP (solid line) and the chromatogram of standard solutions
of thiamine (30 pmol, a), TMP (35 pmol, b) and TPP (25 pmol, c)
(dashed line).
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tion characteristics were found, thus strongly suggesting the
existence of a translocator which can mediate TMP transport
into mitochondria. Km and Vmax values were equal to 180 þ 78
WM and 462 þ 78 pmol/min/mg protein, respectively.
In order to gain a degree of insight into TMP transport,
both the capability of certain inhibitors of mitochondrial car-
riers to a¡ect TMP uptake and TMP capability to a¡ect the
activity of certain mitochondrial translocators were investi-
gated. Mersalyl, butylmalonate, phenylsuccinate and 1,2,3-
benzenetricarboxylate, which are powerful inhibitors of Pi,
dicarboxylate, oxodicarboxylate and tricarboxylate carriers,
respectively [19], failed to inhibit the rate of TMP (60 WM)
uptake into mitochondria. Consistently, when the capability
of 0.5 mM TMP to inhibit the Pi, dicarboxylate, oxodicarbox-
ylate or tricarboxylate translocators was checked as in [18], no
inhibition was found (data not shown). It should be noted
that, in each case, the concentration of the substrate used
was close to its Km value as determined under the same ex-
perimental conditions. These results show that TMP uptake
does not involve the Pi, the dicarboxylate, the oxodicarbox-
ylate or the tricarboxylate translocators.
Interestingly, 50% inhibition of TMP uptake was found in
the presence of CAT (2 WM). It should be noted that CAT has
been previously found to inhibit TPP uptake by RLM [8].
Thus, given that CAT is a powerful speci¢c inhibitor of the
ADP/ATP translocator [20], the capability of TMP to use this
antiporter was checked by measuring the rate of ADP/ATP
exchange. Externally added ADP (5 WM) causes e¥ux of the
newly synthesised ATP with a rate in fairly good agreement
with that expected by considering the Km and Vmax values
previously reported [20]. Both CAT and oligomycin were
found to strongly inhibit ATP appearance outside mitochon-
dria. Conversely, no inhibition was found due to TMP (up to
0.5 mM) addition.
Finally, experiments were carried out to determine whether
TMP can use the carrier which catalyses TPP transport into
mitochondria [8]. To achieve this, ¢rst the capability of exter-
nally added TMP to cause TPP e¥ux from the matrix was
checked with enzymatic measurement of TPP mitochondrial
content. In a set of experiments either RLM or TPP-loaded
RLM were added with TMP and the possible exchange reac-
tion stopped 1 min later. While a 45% decrease of the intra-
mitochondrial TPP content in TPP-loaded RLM was found,
there was no signi¢cant decrease in RLM not loaded with
TPP (data not shown). In another experiment the time course
of TPP uptake by RLM was investigated (Fig. 5). The uptake
reaction was started by the addition of TPP (190 WM) to
isolated RLM and stopped at di¡erent incubation times,
with measurement made of the amount of TPP taken up by
mitochondria. When TPP uptake was complete (about 1 min),
TMP (125 WM) was added. This was found to cause a de-
crease in the TPP content of the mitochondria, consistent with
the e¥ux of the TPP already taken up. As expected in the
light of the existence of a single carrier shared by both TPP
and TMP, the rate of TPP uptake proved to be inhibited by
externally added TMP. The nature of TMP inhibition was
investigated by means of a Dixon plot (Fig. 6). TMP proved
to be a competitive inhibitor of TPP uptake rate with a Ki
value equal to 150 WM.
4. Discussion
This work shows a novel property of RLM: they can me-
tabolise TPP. This occurs in virtue of the presence of an
enzyme exhibiting TPPase activity, localised in the matrix
space of mitochondria. The mitochondrial localisation is
shown both because RLM is essentially free of lysosomes
and microsomes, and more importantly, in the light of both
the digitonin titration and direct TPPase assay in the matrix
fraction of RLM. Our experimental ¢ndings successfully ap-
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Fig. 6. Dixon plot of the TMP inhibition on the rate of TPP up-
take. The TPP uptake reaction was started by the addition of either
22 (b) or 220 WM TPP (F) either in the presence or in the absence
of TMP at the indicated concentrations. The rate of TPP uptake
(V) was enzymatically measured as described in Section 2. Values
are given as the mean of three experiments and reported with their
standard errors.
Fig. 5. Time course of TPP uptake: e¡ect of TMP addition. RLM
(7 mg protein) were incubated for 1 min at 25‡C under the experi-
mental conditions described in Section 2. The uptake reaction was
started by the addition of TPP (190 WM) and stopped at the indi-
cated points in time, with the amount of TPP actually taken up (a)
enzymatically measured as described in Section 2. At the arrow, ei-
ther medium (a) or TMP (125 WM) (b) was added to the mitochon-
drial suspension and the amount of TPP measured at the indicated
points in time. Values are given as the mean of three repeats
( þ S.E.M.) performed using the same mitochondrial preparation.
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ply to certain criteria used to show the occurrence of enzyme
catalysed reactions: the linear interrelationship between the
rate of reaction and amount of the enzyme (mitochondrial
matrix protein in this case), the occurrence of hyperbolic de-
pendence on the substrate concentration, the pH pro¢le and,
¢nally, its inhibition by NaF.
The physiological fate of TMP formed during mitochon-
drial TPP degradation remains quite obscure. Since TMP
can cross the mitochondrial membrane, we assume that, in
the route of its degradation, TMP is converted to thiamine
in the cytoplasm, where TMP phosphohydrolase (EC 3.1.3.-)
is located, thus allowing for new TPP synthesis via the cyto-
solic thiamine pyrophosphokinase [7]. We show here that
TMP can permeate the mitochondrial membrane in a carrier
mediated process, as suggested both by the occurrence of the
hyperbolic dependence on substrate concentration and by the
inhibition of TMP uptake due to CAT. The experimental data
reported in this paper are consistent with the conclusion that
TMP and TPP share the same carrier to cross mitochondrial
membrane. This is substantiated by their mutual inhibition
and by TPP e¥ux from the mitochondria caused by TMP
added to TPP-loaded RLM. The ¢nding that the Ki value is
close to the Km measured for TMP uptake further suggests
that the same translocator could be involved in the transport
of both TPP and TMP. Nonetheless, TMP uptake measured
as an increase in the thiochrome £uorescence, i.e. without
e¥ux of thiamine/thiamine derivatives, supports the existence
of a novel translocator able to mediate TMP uptake in uni-
port and/or in exchange with another anion, perhaps Pi, even
though the possibility that the TPP translocator might exert
the two modes of transport, as reported for the carnitine
carrier (see [21]), cannot be ruled out.
In conclusion, the picture emerging for TPP mitochondrial
metabolism in liver, as obtained by this and our previous
paper [8] is the following: RLM are permeable to TPP and
TMP which is formed in the matrix from TPP imported in a
carrier mediated transport, perhaps in exchange with TMP.
Thus, mitochondria contain carriers and enzymes which can
provide transport for and degradation of their own thiamine
derivatives.
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